Ep. 85 Oral Testosterone Is Here - And It May Change TRT Access w/ Shalin Shah
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
Ep. 85 Oral Testosterone Is Here - And It May Change TRT Access w/ Shalin Shah
-
Letto da:
-
Di:
In this episode of the Physique Revival Podcast, host Alex Gibson interviews Shalin Shah, CEO of Marius Pharmaceuticals, about testosterone therapy and the launch of Kyzatrex, an FDA-approved oral testosterone capsule. Shalin shares his personal journey with low testosterone, the importance of awareness and education around testosterone levels, and the challenges men face in accessing treatment. The conversation also delves into the role of social media in spreading information about testosterone, the FDA's regulations, and the differences between Kyzatrex and other testosterone therapies. Shalin emphasizes the need for proper guidance and diagnostics in testosterone replacement therapy, as well as the significance of maintaining realistic expectations for treatment outcomes.